drugset

drugset / Trial / NCT07686484

A Trial of HRS-3095 in Healthy Volunteers

NCT07686484 ↗

Phase 0 Not yet recruiting 36 enrolled Atridia Pty Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess safety, PK, Pharmacodynamic profile of a single dose of HRS-3095 in healthy participants

Timeline

Start: 2026-07-30
Primary completion: 2026-10-15
Completion: 2026-10-15

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-3095	Unknown	—	Oral

Indications